<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02899923</url>
  </required_header>
  <id_info>
    <org_study_id>PO16091</org_study_id>
    <nct_id>NCT02899923</nct_id>
  </id_info>
  <brief_title>Register of Autoimmune Bullous Dermatoses</brief_title>
  <acronym>REGIBUL</acronym>
  <official_title>Register of Autoimmune Bullous Dermatoses</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CHU de Reims</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CHU de Reims</source>
  <brief_summary>
    <textblock>
      Autoimmune bullous dermatoses are a group of diseases with chronic course. They are provoked
      by the production of autoantibodies against the dermal-epidermal junction or against the
      inter-keratinocyte junctions, resulting in the formation of intra-epidermal or sub-epidermal
      blisters.

      The diagnosis of autoimmune bullous dermatoses is based on clinical and immunopathological
      findings, including skin direct immunofluorescence.

      Systemic corticosteroid therapy is generally considered as the mainstay of treatment for many
      years both for bullous pemphigoid and pemphigus which are the most frequent diseases.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is the creation of a register of patients suffering from autoimmune
      bullous dermatoses to quickly identify patients who can be included in clinical trials or
      retrospective epidemiological studies
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2010</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>autoimmune bullous dermatosis according to physical examination, skin biopsy and autoantibodies detection in blood sample</measure>
    <time_frame>Day 0</time_frame>
    <description>Each autoimmune bullous dermatosis is classified according one of the following diagnoses : 1/ bullous pemphigoid, 2/ Mucous membrane pemphigoid, 3/ Pemphigoid gestationis, 4/ Epidermolysis bullosa acquisita, 5/ Linear IgA bullous dermatosis, 6/ pemphigus (vulgaris or foliaceus)
This classification will be performed according :
clinical characteristics including location, clinical aspect and number of cutaneous and/or mucosal blisters
skin biopsy for routine histology (subepidermal blister or intra-epidermal blister) and direct immunofluorescence (IgG and/or I gA and/or C3 deposits along the epidermal basement membrane zone or on the cell surface of keratinocytes)
blood sample for serum autoantibodies detection against epidermal autoantigens using ELISA or indirect immunofluorescence techniques</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">750</enrollment>
  <condition>Autoimmune Bullous Dermatoses</condition>
  <arm_group>
    <arm_group_label>Autoimmune bullous dermatoses</arm_group_label>
    <description>Patients with autoimmune bullous dermatoses</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection</intervention_name>
    <arm_group_label>Autoimmune bullous dermatoses</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with autoimmune bullous dermatosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with autoimmune bullous dermatosis

          -  patients cared for in dermatology referral center of Reims, Rouen or Limoges

          -  patient consenting to participate to the study

        Exclusion Criteria:

        - patient &lt;18 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2016</study_first_submitted>
  <study_first_submitted_qc>September 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2016</study_first_posted>
  <last_update_submitted>November 20, 2017</last_update_submitted>
  <last_update_submitted_qc>November 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Skin Diseases, Vesiculobullous</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

